RA Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $26.7M | Hold |
|
|||||
|
2022
Q4 | $26M | Hold |
|
|||||
|
2022
Q3 | $51M | Hold |
|
|||||
|
2022
Q2 | $53.8M | Hold |
|
|||||
|
2022
Q1 | $48M | Buy |
|
|||||
|
2021
Q4 | $63.7M | Hold |
|
|||||
|
2021
Q3 | $82.7M | Hold |
|
|||||
|
2021
Q2 | $83.6M | Hold |
|
|||||
|
2021
Q1 | $112M | Hold |
|
|||||
|
2020
Q4 | $143M | Buy |
|